Jerini

Jerini AG

Jerini AG develops peptide-based drugs for patients with rare diseases like hereditary angioedema and collaborates with pharmaceutical companies to treat cancer and inflammatory conditions.

Peroxitech Therapeutics

Peroxitech Therapeutics develops peptide-based treatments for acute lung injury and respiratory distress to serve patients with severe inflammatory conditions.

Bioniz Therapeutics

This clinical-stage biotechnology company develops multi-specific peptide therapeutics to treat patients with autoimmune diseases, inflammatory disorders, and various forms of cancer.

SLRN

This biopharmaceutical company develops and commercialises medicines for patients with immune-mediated and rare diseases.

Ra Pharma

This biotech company develops synthetic macrocyclic peptide therapeutics for patients with rare complement-mediated diseases such as myasthenia gravis.

Crinetics

This pharmaceutical company develops oral therapeutics for patients with rare endocrine diseases and endocrine-related tumours.

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

Mereo BioPharma

The company develops clinical-stage therapies for patients with rare diseases, including osteogenesis imperfecta and alpha-1 antitrypsin deficiency-associated lung disease.